Page last updated: 2024-11-05

tetrahydrophthalimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tetrahydrophthalimide (THPI) is a cyclic imide derived from phthalic anhydride. It is a white crystalline solid with a melting point of 145-148 °C. THPI is used as a monomer in the production of polymers, such as polyimides and polyamides. It is also used as an intermediate in the synthesis of other organic compounds. THPI is a versatile chemical with a wide range of applications, including in the fields of pharmaceuticals, agriculture, and materials science. It is also used as a catalyst in various organic reactions. THPI is a potential candidate for use in the production of novel materials with enhanced properties.'

tetrahydrophthalimide: captan metabolite in fruit crops [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6808
CHEMBL ID3187796
SCHEMBL ID1568506
MeSH IDM0054106

Synonyms (70)

Synonym
1h-isoindole-1,3(2h)-dione, 3a,4,7,7a-tetrahydro-
3a,4,7,7a-tetrahydro-1h-isoindole-1,3(2h)-dione
ccris 3648
nsc 59011
brn 0128764
hsdb 5006
isoindole-1,3-dione, 3a,4,7,7a-tetrahydro-
1h-isoindole-1,3(2h)-dione, 3-alpha,4,7,7-alpha-tetrahydro-
einecs 201-602-8
delta(sup 4)-tetrahydrophthalimide
delta(4)-tetrahydrophthalimide
tetrahydrophthalimide (van)
1,2,3,6-tetrahydrophthalimide
isoindole-1, 3a,4,7,7a-tetrahydro-
nsc59011
1,3,6-tetrahydrophthalimide
.delta.4-tetrahydrophthalimide
nsc-59011
tetrahydrophthalic acid imide
85-40-5
1h-isoindole-1, 3a,4,7,7a-tetrahydro-
4-cyclohexene-1,2-dicarboximide
tetrahydrophthalimide
3a,4,7,7a-tetrahydroisoindole-1,3-dione
FT-0655614
inchi=1/c8h9no2/c10-7-5-3-1-2-4-6(5)8(11)9-7/h1-2,5-6h,3-4h2,(h,9,10,11)
ciffbtojcksrjy-uhfffaoysa-
HMS1722F15
AKOS001040878
NCGC00248318-01
ec 201-602-8
5-21-10-00130 (beilstein handbook reference)
STK724078
dtxcid106513
tox21_301178
dtxsid8026513 ,
cas-85-40-5
NCGC00255076-01
1,2,3,6-tetrahydrophthalimide, 4-cyclohexene-1,2-dicarboximide, thpi
FT-0675043
AKOS025243539
SCHEMBL1568506
AKOS016842521
1,2,3,6-tetrahydrophtalimide
3a,4,7,7a-tetrahydro-1h-isoindole-1,3(2h)-dione #
W-104083
1,2,3,6-tetrahydro phthalimide
FD14008
CHEMBL3187796
3alpha,4,7,7alpha-tetrahydro-1h-isoindole-1,3(2h)-dione
2,3,3a,4,7,7a-hexahydro-1h-isoindole-1,3-dione
mfcd00042782
mfcd00005880
3-hydroxy-3a,4,7,7a-tetrahydro-1h-isoindol-1-one
AC-8837
tetrahydrophthalimid
3a,4,7,7a-tetrahydro-cis-1h-isoindole-1,3(2h)-dione
3-alpha,4,7,7-alpha-tetrahydro-1h-isoindole-1,3(2h)-dione
3a,4,7,7a-tetrahydro-isoindole-1,3-dione
laquo deltaraquo 4-tetrahydrophthalimide
1,2,5,6-tetrahydrophthalimide
SY003867
CS-0077658
FT-0739667
Q21045269
AMY10828
EN300-05179
SB66392
SY102061
Z56893117
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
progesterone receptorHomo sapiens (human)Potency0.24340.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency54.48270.003041.611522,387.1992AID1159552
thyroid stimulating hormone receptorHomo sapiens (human)Potency2.73060.001628.015177.1139AID1259385
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (28.57)18.7374
1990's3 (14.29)18.2507
2000's1 (4.76)29.6817
2010's11 (52.38)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.70 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index45.47 (26.88)
Search Engine Supply Index2.29 (0.95)

This Compound (32.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (7.69%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (3.85%)4.05%
Observational0 (0.00%)0.25%
Other23 (88.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]